Search alternatives:
significant risk » significant role (Expand Search)
point decrease » point increase (Expand Search)
sizes decrease » scores decreased (Expand Search), rivers decreased (Expand Search)
Showing 1 - 20 results of 6,183 for search '(( significant risk decrease ) OR ( significant ((point decrease) OR (sizes decrease)) ))', query time: 0.58s Refine Results
  1. 1
    Changes in sodium levels, serving sizes, and calories in matched restaurant menu items (2016–2020) by sodium reduction or increase.

    Changes in sodium levels, serving sizes, and calories in matched restaurant menu items (2016–2020) by sodium reduction or increase. by Caroline G. Middleton (22041479)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    HFD decreases intermediate-term memory.

    HFD decreases intermediate-term memory. by Tong Yue (6033305)

    Published 2025
    “…<p>(A) The survival rate of 10d <i>Canton-S</i> fed with ND or HFD was observed for 7 days. There was no significant decline in the survival rate in flies fed with HFD compared with ND (n = 10 vials, containing 20 flies at each time point). …”
    Save to List
    Saved in:
  3. 3
    Schematic diagram of experimental injector size.

    Schematic diagram of experimental injector size. by Lei Bai (631944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Line graph showing the increase or decrease in the average number of bee swarms caught over the past three years (Mean 

    Line graph showing the increase or decrease in the average number of bee swarms caught over the past three years (Mean  by Beatrice T. Nganso (4114768)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Risk Classification Diagram of Hot Surface.

    Risk Classification Diagram of Hot Surface. by Lei Bai (631944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    iKIR score decreases protection associated with protective class II genotypes in T1D.

    iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

    Published 2024
    Save to List
    Saved in:
  7. 7
    Box plot show that there are no differences between different groups of the size of pus cavity.

    Box plot show that there are no differences between different groups of the size of pus cavity. by Na Wang (193263)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 8
    Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity.

    Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity. by Jing Wang (6206297)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: